A Mobile Infliximab Dosing Calculator for Therapy Optimization in Inflammatory Bowel Disease

BACKGROUND: Inadequate infliximab (IFX) drug exposure remains a clinical challenge and leads to high loss of response rates and therapy failure in inflammatory bowel disease (IBD). We aimed to determine the feasibility and pilot effectiveness of a novel, web-based, mobile IFX dosing calculator (mIDC...

Descripción completa

Detalles Bibliográficos
Autores principales: Piester, Travis, Frymoyer, Adam, Christofferson, Megan, Yu, Helen, Bass, Dorsey, Park, K T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
IBD Live
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048868/
https://www.ncbi.nlm.nih.gov/pubmed/29361094
http://dx.doi.org/10.1093/ibd/izx037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048868/
https://www.ncbi.nlm.nih.gov/pubmed/29361094
http://dx.doi.org/10.1093/ibd/izx037

Ejemplares similares